Combination & Conjugate Vaccines


Track 4: Combination & Conjugate Vaccines

Increasingly, more diseases are becoming vaccine preventable, but maintaining community and provider acceptance demands that the number of injections doesn’t increase. Combination conjugate vaccines represent an inevitable and important advance. This paper reviews the efficacy and safety of combination conjugate vaccines, including immunological mechanisms underlying interactions among vaccine epitopes, the role of immunological memory, and correlates of immunity. Specific attention is given to the experience with combination vaccines against each of Haemophilus influenzae type bStreptococcus pneumoniae  and Neisseria meningitidis. The implications of these findings for different communities are discussed, key areas for further research identified and implications for post-licensure monitoring addressed.


    Related Conference of Combination & Conjugate Vaccines

    November 04-05, 2022

    34th Annual Congress on Vaccine and Clinical Trials

    Toronto, Canada
    November 17-18, 2022

    2nd Global Summit on Vaccines and Immunology

    Berlin, Germany
    February 20-21, 2023

    International Conference on Vaccine Research

    Madrid, Spain
    November 06-07, 2023

    5th World Congress on Vaccine and Immunology

    Tokyo, Japan

    Combination & Conjugate Vaccines Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in